Monotherapy update from Phase 1 portion in Phase1/2 trial of the menin-MLL inhibitor enzomenib (DSP-5336) in patients with relapsed or refractory acute leukemia
Por:
Daver, N, Zeidner, J, Watts, J, Yuda, J, Levis, M, Montesinos, P, Papayannidis, C, Fukushima, K, Shima, T, Raffoux, E, Borate, U, Palmisiano, N, Brandwein, J, Heiblig, M, Miyazaki, Y, Ikezoe, T, Ooi, M, Wu, SJ, Wang, E, Vives, S, Strickland, S, Breems, D, Hosono, TN, Ogawa, Y, Onodera, K, Brunner, A, Keiffer, G, Pardee, T, Shami, P, Eghtedar, A, Cai, HL, Xu, B, Robson, P, Watanabe, A, Hitron, M, Shah, J, Kantarjian, H and Erba, H
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Daver, N:
Univ Texas MD Anderson Canc Ctr, Houston, TX USA
Zeidner, J:
Univ North Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
Watts, J:
Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL USA
Yuda, J:
Natl Canc Ctr Hosp East, Kashiwa, Japan
Levis, M:
Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
Montesinos, P:
Hosp Univ & Politecn La Fe, Valencia, Spain
Papayannidis, C:
Ist Ematol Seragnoli, IRCCS Azienda Osped Univ Bologna, Bologna, Italy
Fukushima, K:
Univ Osaka, Grad Sch Med, Suita, Japan
Shima, T:
Kyushu Univ, Grad Sch Med Sci, Fukuoka, Japan
Raffoux, E:
St Louis Univ Hosp, AP HP Paris, Inst Leucemie St Louis, Paris, France
Borate, U:
Ohio State Univ, Columbus, OH USA
Palmisiano, N:
Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
Brandwein, J:
Univ Alberta, Edmonton, AB, Canada
Heiblig, M:
Hosp Civils Lyon, Lyon, France
Miyazaki, Y:
Nagasaki Univ Hosp, Nagasaki, Japan
Ikezoe, T:
Fukushima Med Univ, Fukushima, Japan
Ooi, M:
Natl Univ, Canc Inst, Singapore, Singapore
Wu, SJ:
Natl Taiwan Univ Hosp, Taipei, Taiwan
Wang, E:
Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
:
Hosp Germans Trias i Pujol, Inst Catala Oncol Badalona, Badalona, Spain
Strickland, S:
TriStar Centennial, SCRI, Nashville, TN USA
Breems, D:
Ziekenhuis Stroom, Antwerp, Belgium
Hosono, TN:
Univ Fukui, Fukui, Japan
Ogawa, Y:
Tokai Univ, Sch Med, Kanagawa, Japan
Onodera, K:
Tohoku Univ, Grad Sch Med, Sendai, Japan
Brunner, A:
Massachusetts Gen Hosp, Boston, MA USA
Keiffer, G:
Thomas Jefferson Univ, Sidney Kimmel Comprehens Canc Ctr, Philadelphia, PA USA
Pardee, T:
Atrium Hlth Wake Forest Baptist, Comprehens Canc Ctr, Winston Salem, NC USA
Shami, P:
Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
Eghtedar, A:
Colorado Blood Canc Inst, Denver, CO USA
Cai, HL:
Sumitomo Pharm Amer, Marlborough, MA USA
Xu, B:
Sumitomo Pharm Amer, Marlborough, MA USA
Robson, P:
Sumitomo Pharm Amer, Marlborough, MA USA
Watanabe, A:
Sumitomo Pharm Amer, Marlborough, MA USA
Hitron, M:
Sumitomo Pharm Amer, Marlborough, MA USA
Shah, J:
Sumitomo Pharm Amer, Marlborough, MA USA
Kantarjian, H:
Sumitomo Pharm Amer, Marlborough, MA USA
Erba, H:
Duke Canc Inst, Durham, NC USA
|